𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The impact of a quadrivalent human papillomavirus (types 6, 11, 16, 18) virus-like particle vaccine in European women aged 16 to 24

✍ Scribed by S Majewski; FX Bosch; J. Dillner; O-E Iversen; SK Kjaer; N Muñoz; S-E Olsson; J Paavonen; K Sigurdsson; J Bryan; MT Esser; K Giacoletti; M James; F Taddeo; S Vuocolo; E Barr

Book ID
111096002
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
229 KB
Volume
23
Category
Article
ISSN
0926-9959

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, immunogenicity, and efficacy of
Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 virus-like-particle vaccine in Latin American women
✍ Gonzalo Perez; Eduardo Lazcano-Ponce; Mauricio Hernandez-Avila; Patricia J. Garc 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract The prevalence of HPV infection in Latin America is among the highest in the world. A quadrivalent (types 6/11/16/18) human papillomavirus L1 virus‐like‐particle vaccine has been shown to be 95–100% effective in preventing HPV 6/11/16/18‐related cervical and genital disease in women naï